rs6439886
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022131.3(CLSTN2):c.109+28170A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 152,192 control chromosomes in the GnomAD database, including 1,604 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1604 hom., cov: 32)
Consequence
CLSTN2
NM_022131.3 intron
NM_022131.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.348
Publications
19 publications found
Genes affected
CLSTN2 (HGNC:17448): (calsyntenin 2) Predicted to enable calcium ion binding activity. Predicted to be involved in positive regulation of synapse assembly and positive regulation of synaptic transmission. Predicted to be located in postsynaptic density. Predicted to be active in cell surface; glutamatergic synapse; and postsynaptic membrane. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLSTN2 | NM_022131.3 | c.109+28170A>G | intron_variant | Intron 1 of 16 | ENST00000458420.7 | NP_071414.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21074AN: 152074Hom.: 1602 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21074
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.139 AC: 21090AN: 152192Hom.: 1604 Cov.: 32 AF XY: 0.136 AC XY: 10125AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
21090
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
10125
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
7396
AN:
41520
American (AMR)
AF:
AC:
1324
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
472
AN:
3470
East Asian (EAS)
AF:
AC:
440
AN:
5170
South Asian (SAS)
AF:
AC:
448
AN:
4820
European-Finnish (FIN)
AF:
AC:
1568
AN:
10594
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9085
AN:
68006
Other (OTH)
AF:
AC:
245
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
939
1878
2818
3757
4696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
287
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.